1. Home
  2. MDGL vs ZWS Comparison

MDGL vs ZWS Comparison

Compare MDGL & ZWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$511.93

Market Cap

11.5B

Sector

Health Care

ML Signal

HOLD

Logo Zurn Elkay Water Solutions Corporation

ZWS

Zurn Elkay Water Solutions Corporation

HOLD

Current Price

$47.54

Market Cap

7.9B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDGL
ZWS
Founded
2011
1900
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
11.5B
7.9B
IPO Year
2005
2008

Fundamental Metrics

Financial Performance
Metric
MDGL
ZWS
Price
$511.93
$47.54
Analyst Decision
Strong Buy
Buy
Analyst Count
12
6
Target Price
$674.45
$53.67
AVG Volume (30 Days)
255.9K
947.9K
Earning Date
05-06-2026
04-21-2026
Dividend Yield
N/A
0.86%
EPS Growth
41.32
25.00
EPS
N/A
0.35
Revenue
$180,133,000.00
$1,530,500,000.00
Revenue This Year
$58.39
$6.90
Revenue Next Year
$48.55
$5.13
P/E Ratio
N/A
$132.77
Revenue Growth
N/A
19.40
52 Week Low
$265.00
$35.06
52 Week High
$615.00
$53.76

Technical Indicators

Market Signals
Indicator
MDGL
ZWS
Relative Strength Index (RSI) 48.77 42.08
Support Level $498.34 $45.70
Resistance Level $556.79 $48.40
Average True Range (ATR) 23.64 1.14
MACD -1.69 -0.59
Stochastic Oscillator 32.79 22.10

Price Performance

Historical Comparison
MDGL
ZWS

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

About ZWS Zurn Elkay Water Solutions Corporation

Zurn Elkay Water Solutions Corp is a growth-oriented, pure-play water management business that designs, procures, manufactures, and markets the broadest sustainable product portfolio of specification-driven water management solutions to improve health, hydration, human safety and the environment. Its product portfolio includes professional grade water safety and control products, flow systems products, hygienic and environmental products, and filtered drinking water products for public and private spaces that deliver superior value to building owners, positively impact the environment and human hygiene and reduce product installation time.

Share on Social Networks: